Clonazepam Recall 2025 Calendar. Birth Control Recall 2025 List Gabi Myranda would expand an existing recall of Clonazepam Orally Disintegrating Tablets, USP (C-IV) over concerns that the packaging had been mislabeled with the incorrect dosing. • On November , O Q, Endo announced a voluntary, consumer level recall of many lots of clonazepam ODT tablets because of potential product carton strength mislabeling
Clonazepam, or Klonopin, recall over mislabeled packages What to know from www.usatoday.com
• On November , O Q, Endo announced a voluntary, consumer level recall of many lots of clonazepam ODT tablets because of potential product carton strength mislabeling would expand an existing recall of Clonazepam Orally Disintegrating Tablets, USP (C-IV) over concerns that the packaging had been mislabeled with the incorrect dosing.
Clonazepam, or Klonopin, recall over mislabeled packages What to know
Clonazepam oral tablet, Teva, 0.5 mg, bottle, 100 count, NDC 00093-0832-01; Reason for the Shortage The recall affects Clonazepam Orally Disintegrating Tablets, USP, 1 milligram (mg), which are available by prescription only in cartons of blister packs containing 60. Clonazepam oral tablet, Teva, 0.5 mg, bottle, 100 count, NDC 00093-0832-01; Reason for the Shortage
Clonazepam recall expanded due to misprinted packaging. • Clonazepam orally disintegrating tablets were distributed nationwide between January and October Q O Q S. The recall affects Clonazepam Orally Disintegrating Tablets, USP, 1 milligram (mg), which are available by prescription only in cartons of blister packs containing 60.
Clonazepam Overdose (Klonopin). However, the blister strips and tablets inside the product pack reflect the correct strength for the lot. The expanded recall involves Clonazepam Orally Disintegrating Tablets, with strength in USP 0.125 mg, 0.25 mg, 1 mg, and 2mg, packaged in cartons containing 60 tablets packed into 10 blister strips each containing 6 tablets, with various lot codes and National Drug Code or NDC.